Amphastar Pharmaceuticals AMPH Number of reportable segments

Other financials

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Market cap$927.72M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×